Pharming Group N.V.
General ticker "PHGUF" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $1.0B (TTM average)
Pharming Group N.V. follows the US Stock Market performance with the rate: 15.9%.
Estimated limits based on current volatility of 0.8%: low 1.14$, high 1.16$
Factors to consider:
- Current price 13.8% below estimated low
- Earnings for 3 months up through Q1 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [1.33$, 2.58$]
- 2026-12-31 to 2027-12-31 estimated range: [1.36$, 2.59$]
Short-term PHGUF quotes
Long-term PHGUF plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $245.32MM | $297.20MM | $391.32MM |
| Operating Expenses | $267.61MM | $300.87MM | $371.23MM |
| Operating Income | $-22.29MM | $-3.67MM | $20.09MM |
| Non-Operating Income | $10.28MM | $-4.83MM | $-6.73MM |
| Interest Expense | $5.96MM | $9.52MM | $11.36MM |
| R&D Expense | $68.91MM | $83.15MM | $104.42MM |
| Income(Loss) | $-12.01MM | $-8.49MM | $13.37MM |
| Taxes | $-1.46MM | $0.00MM | $10.73MM |
| Net Income(Loss)* | $-11.54MM | $-11.84MM | $2.97MM |
| Stockholders Equity | $218.78MM | $221.06MM | $277.03MM |
| Inventory | $56.76MM | $55.72MM | $64.89MM |
| Assets | $462.85MM | $399.99MM | $499.84MM |
| Operating Cash Flow | $-17.30MM | $-1.79MM | $51.94MM |
| Capital expenditure | $1.46MM | $0.80MM | $0.78MM |
| Investing Cash Flow | $-129.39MM | $31.62MM | $19.12MM |
| Financing Cash Flow | $-0.94MM | $-34.41MM | $15.02MM |
| Earnings Per Share** | $-0.02 | $-0.02 | $0.00 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.